Kure Care, a division of Veracor Group LLC, urges Medicare beneficiaries with chronic wounds to seek regenerative treatment before January 1, 2026 Medicare reimbursement changes. The company offers ...

Ongoing Enrollment Continues in VALUE Phase III Trial of EscharEx® in Venous Leg Ulcers Commissioning Completed for Expanded NexoBrid® Facility; ...

IRVINE, CA / ACCESS Newswire / November 13, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) (“enVVeno” or the “Company”), a company setting new standards of care for the treatment of deep venous ...

MediWound Ltd. (NASDAQ: MDWD) Q3 2025 Earnings Call Transcript November 20, 2025 MediWound Ltd. beats earnings expectations.

Varicose veins, a condition marked by abnormally swollen and twisted veins near the skin surface, often described as “bulging ...

Mediwound ( ($MDWD) ) has released its Q3 earnings. Here is a breakdown of the information Mediwound presented to its investors. MediWound Ltd., a ...

The latest announcement is out from Mediwound ( (MDWD) ).

Peripheral Artery Disease, the narrowing of blood vessels in the legs, has exploded in prevalence. Data from the Global ...

CNW/ - Medunik USA, a specialty pharmaceutical company, and part of Duchesnay Pharmaceutical Group (DPG), is dedicated to providing patients with rare diseases access to orphan drugs. Medunik USA is ...

Simultaneous kidney and pancreas transplants are a life-saving option for people with Type 1 diabetes. Survival rates after ...

Ongoing Enrollment Continues in VALUE Phase III Trial of EscharEx- in Venous Leg Ulcers Commissioning Completed for Expanded NexoBrid- Facility; Full Operational Capacity Expected by Year-End 2025 ...